Successful laparoscopic surgical removal of a caesarean scar pregnancy (CSP) using temporary uterine artery ligation

J Minim Invasive Gynecol. 2022 Dec;29(12):1292-1293. doi: 10.1016/j.jmig.2022.09.011. Epub 2022 Sep 22.

Abstract

Study objective: To demonstrate a laparoscopic technique to remove a scar pregnancy.

Design: Stepwise demonstration of the surgical technique.

Setting: Santa Croce and Carle Hospital, Cuneo.

Intervention: Patient B.B. is a woman referred to our center for a suspected cesarean scar pregnancy (CSP) at 9 weeks gestation. CSP occurs approximately in 6% of all ectopic pregnancies. The estimated incidence is reported to be 1:1800 to 1:2500 in cesarean deliveries. Depending on its location, CSP can be categorized as either type 1, if the growth is in the uterine cavity, or type 2, if it expands toward the bladder and the abdominal cavity. If inadequately managed, it can lead to severe complications; most of them are hemorrhagic and can threaten the woman's life. There are several therapeutic approaches: local excision seems to be the most effective choice in type 2 CSP. In expert hands, the laparoscopic approach is perhaps the best surgical choice as tissue dissection, electrosurgical hemostasis, and vascular control can be effectively managed with minimal invasive access. Because severe intraoperative bleeding can occur, retroperitoneal vascular control is mandatory in this surgery. In type 1 CSP curettage, aspiration or hysteroscopic approach can be considered if the CSP is of small dimensions. A hysteroscopic approach can also be helpful in type 2 CSP during the laparoscopic removal, as intrauterine guidance. A potassium chloride local injection can be considered in a preoperative stage in the presence of a fetal heart rate. The systemic administration of methotrexate is usually ineffective as single agent, but it can be useful if administered as adjuvant therapy. Uterine artery embolization can be useful in an emergency setting to manage severe bleeding, but it can lead to complications in subsequent pregnancies and, more rarely, to premature ovarian failure. Considering poor bleeding at presentation, feasible dimensions, and the woman's desire for future pregnancy, ultrasound-guided aspiration and curettage was attempted. Because endouterine removal was incomplete, methotrexate injection was proposed as adjuvant therapy, but the administration was postponed as the patient tested positive for coronavirus disease 2019. A month later, beta-human chorionic gonadotropin level dropped from over 16 000 to 271 mU/mL, so an ultrasound and biochemical follow-up was performed. A month later, despite a low beta-human chorionic gonadotropin value, an increase in dimensions was observed at ultrasound, so surgical laparoscopic removal was offered. In this video article, laparoscopic removal of scar pregnancy is discussed in the following surgical steps: (1) Temporary closure of uterine arteries at the origin, using removable clips. (2) Retroperitoneal dissection to safely manage the scar pregnancy. (3) Dissection of the myometrial-pregnancy interface. (4) Double layer suture on the anterior uterine wall.

Conclusion: Laparoscopic surgical management is a very effective surgical approach to remove CSP. Knowledge of retroperitoneal dissection and vascular control is necessary to carry out this surgical intervention safely and effectively.

Keywords: Ectopic pregnancy; Laparoscopic surgery; Pelvic anatomy; Retroperitoneal dissection.

Publication types

  • Case Reports
  • Video-Audio Media

MeSH terms

  • COVID-19 / complications
  • Cesarean Section / adverse effects
  • Chorionic Gonadotropin, beta Subunit, Human
  • Cicatrix / complications
  • Cicatrix / surgery
  • Female
  • Humans
  • Laparoscopy* / methods
  • Methotrexate / therapeutic use
  • Pregnancy
  • Pregnancy, Ectopic* / etiology
  • Pregnancy, Ectopic* / surgery
  • Retrospective Studies
  • Treatment Outcome
  • Uterine Artery / pathology
  • Uterine Artery / surgery

Substances

  • Chorionic Gonadotropin, beta Subunit, Human
  • Methotrexate